3rd Quarter - Report

CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. for PANCREATIC CANCER ACTION NETWORK (PANCAN)

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

H.R. 9495/S. Unnumbered, FY 2027 Defense Appropriations Act, Pancreatic Cancer Research Program; H.R. 9260/S. Unnumbered FY 2027 Labor-Health and Human Services-Education Appropriations Act, NIH research on pancreatic cancer

LobbyistCovered position, as disclosed
STEFANI RINEHART —
MARK VIETH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 9260 (119th), H.R. 9495 (119th)

Defense DEF

H.R. 9495/S. Unnumbered, FY 2027 Defense Appropriations Act, Pancreatic Cancer Research Program

LobbyistCovered position, as disclosed
STEFANI RINEHART —
MARK VIETH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 9495 (119th)

Budget/Appropriations BUD

H.R 9495/S. Unnumbered, FY 2027 Defense Appropriations Act, Pancreatic Cancer Research Program; H.R. 9260/S. Unnumbered, FY 2027 Labor-Health and Human Services-Education Appropriations Act, NIH research on pancreatic cancer

LobbyistCovered position, as disclosed
STEFANI RINEHART —
MARK VIETH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 9260 (119th), H.R. 9495 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.